November 19, 2020
FDA authorizes first home test for COVID-19
Editor's Note
The Food and Drug Administration (FDA) on November 17 issued an emergency use authorization for the first rapid COVID-19 self-test that a person can administer at home.
The Lucira COVID-19 All-In-One Test Kit has to be prescribed by a healthcare provider, and the healthcare provider has to report the results to public health authorities. The home test is for those 14 years of age or older.
The test also can be used in patient care settings, with nasal swab specimens collected by the provider in those under age 14.
Free Daily News
- C-sections linked to longer recovery, higher pain, sleep problems for new mothers
- AI model grades nursing procedures with near-human precision
- Study: Hospitals can safely cut low-value preop tests before routine surgeries
- New studies highlight opportunities to improve pediatric anesthesia safety, comfort
- Social and behavioral factors emerging as key predictors of recovery quality after surgery
- Hospitals being squeezed: Anesthesia workforce gaps, payer cuts threaten surgery access
- CDC layoffs cripple national injury and overdose tracking, leaving prevention efforts in doubt
- The Joint Commission makes nurse staffing a national performance goal for 2026
- Telehealth in limbo: Providers split on continuing Medicare services during shutdown
- States take aim at outpatient facility fees driving higher commercial health costs
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement